Preeclampsia and Circulating Biomarkers
1 other identifier
observational
64
1 country
1
Brief Summary
In order to assess circulating biomarkers of cardiovascular risk, we will conduct a 10-year follow-up study comparing 32 exposed (women with a history of pregnancy complicated by preeclampsia) and 32 unexposed (women with a history of uncomplicated pregnancy). Participants will be recruited from a well-characterised cohort, previously assembled during their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in 2001-2004. Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus rendering the possibility of longitudinal assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 1, 2014
CompletedFirst Posted
Study publicly available on registry
May 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 6, 2015
May 1, 2014
8 months
May 1, 2014
January 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Circulating biomarkers of cardiovascular disease 10 years postpartum.
10 years postpartum
Secondary Outcomes (2)
Markers of arteriosclerosis and atherosclerosis
10 years postpartum
Circulating biomarkers of cardiovascular disease at baseline pregnancy.
During pregnancy
Study Arms (2)
Exposed
Women with a history of preeclampsia 10 years ago
Unexposed
Women with a history of uncomplicated pregnancy 10 years ago
Eligibility Criteria
Participants will be recruited from a well-characterised cohort, previously assembled at the Department of Obstetrics at Randers Regional Hospital in 2001-2005.
You may qualify if:
- Participation in previous study 2001-2005.
You may not qualify if:
- Current pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Randers Regional Hospitalcollaborator
- Karen Elise Jensen Foundationcollaborator
- Central Denmark Regioncollaborator
Study Sites (1)
Randers Regional Hospital
Randers, Randers NØ, 8930, Denmark
Biospecimen
Blood serum Blood plasma Urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ulla B Knudsen, Professor
Department of Obstetrics and Gynaecology, Aarhus University Hospital
- PRINCIPAL INVESTIGATOR
Martin Christensen, MD
Clinical Research Unit, Randers Regional Hospital
- STUDY DIRECTOR
Camilla S Kronborg, MD, PhD
Department of Oncology, Aarhus University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2014
First Posted
May 13, 2014
Study Start
April 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2015
Last Updated
January 6, 2015
Record last verified: 2014-05